Proteogenomic profiling of acute myeloid leukemia to identify therapeutic targets
{{output}}
Introduction: Acute myeloid leukemia (AML) is an aggressive and poor-prognosis blood cancer. Despite a low mutation burden compared to other cancers, AML is heterogenous and identifying robust therapeutic targets has been difficu... ...
